の Italian Medicines Agency (AIFA) recently published news regarding a new document ‘Questions & Answers Version 1.0’. In order to facilitate the implementation of new Clinical Trial Regulations.
This document collects the Questions & Answers already published on the AIFA institutional website, grouping them by type, with updates and the addition of new Q&As. The document will be progressively updated by AIFA. The Questions & Answers are specific to Italy and relate to questions that are not already present in the documents published by the European Commission.
- RegASK DCT ガイドブックがどのように役立つかについては、以下をご覧ください。 規制ガイドブックが分散型臨床試験への道を開いた
- DCT 規制の変更についてさらに詳しく知りたいですか? RegASK の専門家にお問い合わせください。